Parallel Bio secures $21m to advance human-first drug discovery
Biotech company Parallel Bio has raised $21 million in a Series A funding led by AIX Ventures. The round attracted new investors Amplo and Marc Benioff, founder and CEO of Salesforce, and existing investors Metaplanet, Humba Ventures, Atypical Ventures, Undeterred Capital, and Jeff Dean. Robert… Read More